Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,814
Out of 4,829 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $6.90 | -82.61% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $1.64 | +29,145.11% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $750,000 | $1.14 | +65,789,373.68% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $6.29 | +35,671.07% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $39.42 | +432.72% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $6.90
Upside: -82.61%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $1.64
Upside: +29,145.11%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $750,000
Current: $1.14
Upside: +65,789,373.68%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $6.29
Upside: +35,671.07%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $39.42
Upside: +432.72%